Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID | UniProt ID ▲ | Title | Descriptor |
|---|---|---|---|
| 8PN5 | 8PN5 | Crystal structure of the HC7-Glu200Ala mutant complexed to a triglycopeptide | |
| 8PQ2 | 8PQ2 | XBB 1.0 RBD bound to P4J15 (Local) | |
| 8PVB | 8PVB | Structure of GABAAR determined by cryoEM at 100 keV | |
| 8PWH | 8PWH | Atomic structure and conformational variability of the HER2-Trastuzumab-Pertuzumab complex | |
| 8PXY | 8PXY | Crystal structure of the transpeptidase LdtMt2 C354S mutant from Mycobacterium tuberculosis in complex with natural substrate | |
| 8Q6J | 8Q6J | Atomic structure and conformational variability of the HER2-Trastuzumab-Pertuzumab complex | |
| 8QFX | 8QFX | Human Angiotensin-1 converting enzyme N-domain in complex with the lactotripeptide IPP | |
| 8QH0 | 8QH0 | Crystal structure of the SARS-CoV-2 RBD with the antibody Cv2.3194 | |
| 8QH1 | 8QH1 | Crystal structure of the SARS-CoV-2 RBD from the Omicron BA4 variant with the antibody Cv2.3194 | |
| 8QHL | 8QHL | Human Angiotensin-1 converting enzyme N-domain in complex with the lactotripeptide VPP | |
| 8QKE | 8QKE | PvSub1 Catalytic Domain in Complex with Peptidomimetic Inhibitor (MH-13) | |
| 8QKG | 8QKG | PvSub1 Catalytic Domain in Complex with Peptidomimetic Inhibitor (MAM-125) | |
| 8QKJ | 8QKJ | PvSub1 Catalytic Domain in Complex with Peptidomimetic Inhibitor (MAM-133) | |
| 8QPR | 8QPR | SARS-CoV-2 S protein bound to human neutralising antibody UZGENT_G5 | |
| 8QQ0 | 8QQ0 | SARS-CoV-2 S protein bound to neutralising antibody UZGENT_A3 | |
| 8QRF | 8QRF | SARS-CoV-2 delta RBD complexed with XBB-6 and beta-49 Fabs | |
| 8QRG | 8QRG | SARS-CoV-2 delta RBD complexed with XBB-2 Fab and NbC1 | |
| 8QYA | 8QYA | J22.9-FNY, fully humanized, CDR optimized Fab Fragment based on chimeric J22.9-xi IgG against BCMA; with VH CDR2 glycosylation | |
| 8QZR | 8QZR | SARS-CoV-2 delta RBD complexed with BA.4/5-9 Fab | |
| 8R1C | 8R1C | SD1-2 Fab in complex with SARS-CoV-2 BA.2.12.1 Spike Glycoprotein | |
| 8R1D | 8R1D | SD1-3 Fab in complex with SARS-CoV-2 BA.2.12.1 Spike Glycoprotein | |
| 8R8D | 8R8D | Cryo-EM structure of coagulation factor beta-XIIa in complex with the garadacimab Fab fragment (symmetric dimer) | |
| 8R9W | 8R9W | PDCoV spike glycoprotein ectodomain in complex with the 22C10 antibody Fab fragment | |
| 8R9X | 8R9X | Local refinement of the PDCoV spike glycoprotein ectodomain in complex with the 22C10 antibody Fab fragment | |
| 8R9Y | 8R9Y | S1B domain of the PDCoV spike glycoprotein in complex with the 67B12 and 42H3 antibody Fab fragments | |
| 8R9Z | 8R9Z | S1B domain of the PDCoV spike glycoprotein in complex with the 67B12 and 46E6 antibody Fab fragments | |
| 8RP8 | 8RP8 | Structure of K2 Fab in complex with human CD47 ECD | |
| 8RUU | 8RUU | Fabs derived from bimekizumab in complex with IL-17F | |
| 8S0L | 8S0L | Crystal structure of the TMPRSS2 zymogen in complex with the nanobody A07 | |
| 8S0M | 8S0M | Crystal structure of the HKU1 receptor binding domain in complex with TMPRSS2 and the nanobody A01 | |
| 8S2E | 8S2E | Fab4251-DS-SOSIP complex | |
| 8S9G | 8S9G | SARS-CoV-2 BN.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment | |
| 8SAK | 8SAK | BtCoV-422 in complex with neutralizing antibody JC57-11 | |
| 8SAN | 8SAN | CryoEM structure of VRC01-CH848.0836.10 | |
| 8SAQ | 8SAQ | CryoEM structure of DH270.6-CH848.0526.25 | |
| 8SAR | 8SAR | CryoEM structure of DH270.6-CH848.10.17 | |
| 8SAS | 8SAS | CryoEM structure of DH270.5-CH848.10.17 | |
| 8SAU | 8SAU | CryoEM structure of DH270.4-CH848.10.17 | |
| 8SAV | 8SAV | CryoEM structure of VRC01-CH848.0526.25 | |
| 8SAW | 8SAW | CryoEM structure of DH270.UCA.G57R-CH848.10.17DT | |
| 8SAX | 8SAX | CryoEM structure of DH270.UCA-CH848.10.17DT | |
| 8SAY | 8SAY | CryoEM structure of DH270.3-CH848.10.17 | |
| 8SAZ | 8SAZ | CryoEM structure of DH270.I5.6-CH848.10.17 | |
| 8SB0 | 8SB0 | CryoEM structure of DH270.I4.6-CH848.10.17 | |
| 8SB1 | 8SB1 | CryoEM structure of DH270.I3-CH848.10.17 | |
| 8SB2 | 8SB2 | CryoEM structure of DH270.I2-CH848.10.17 | |
| 8SB3 | 8SB3 | CryoEM structure of DH270.2-CH848.10.17 | |
| 8SB4 | 8SB4 | CryoEM structure of DH270.1-CH848.10.17 | |
| 8SB5 | 8SB5 | CryoEM structure of DH270.I1.6-CH848.10.17 | |
| 8SDF | 8SDF | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC25.4 |
